open heart surgery
Conditions
Interventions
Ulinastatin Group:Use Ulinastatin
Control Group:Use NS
Sponsors
The Second Affiliated Hospital of Nantong University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients scheduled for cardiopulmonary bypass during open heart surgery will be enrolled in this study.
Exclusion criteria
Exclusion criteria: With a history of significant renal, hepatic, neurological and pulmonary inflammatory disease, recent use of antiinflammatory or antioxidation drugs, long term use of glucocorticoidor or immunodepressant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concentration of TNF-a;Concentration of IL-6;Concentration of IL-8;Concentration of 8-isoPG F2a;Concentration of H2O2;Results of Blood Gas Analysis;Occurrence of ALI; | — |
Secondary
| Measure | Time frame |
|---|---|
| extubation time;Duration of ICU;Discharge Time;Other Complications; | — |
Countries
China
Contacts
Public ContactJie Song
The Second Affiliated Hospital of Nantong University
Outcome results
None listed